Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-07-01-Speech-2-148"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-07-01"^^xsd:date2
dcterms:Is Part Of	lp_eu:Strengthening the European pharmaceutical industry in the interest of patients – proposals for action2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20030701.6.2-148"2
lpv:hasSubsequent	lp_eu:2003-07-01-Speech-2-1492
lpv:speaker	lp:Liikanen2
lpv:spoken text	". Mr President, I must emphasise that the two proposals are separate as far as the review is concerned. The review is supported by G10 and now has the support of the Member States. The G10 process goes further, and so far there has not been any broad discussion in the Member States about that. There is, firstly, a proposal from the Group and today there are the recommendations from the Commission. Next week the Italian Presidency is organising a conference on G10 on the basis of the Commission recommendations. We hope that the dissemination of these messages goes forward. As I said, it is now important to get the review through. That is important for research-based industries because it strengthens their position; it accelerates the access to markets for new products; it acts as a counterbalance; and it also means that generics will be more competitive when the patents expire."@en1
lpv:unclassifiedMetadata	"Commission"1 "Liikanen,"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph